MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Bluegrass Vascular taps ex-ArthoCare R&D chief Niederauer for CEO | Personnel Moves

Bluegrass Vascular taps ex-ArthoCare R&D chief Niederauer for CEO | Personnel Moves

By

Bluegrass Vascular taps ex-ArthoCare R&D chief Niederauer for CEO | Personnel Moves

Bluegrass Vascular Technologies said it named Gabriele Niederauer its new president & CEO, hard on the heels of a Series A funding round that brought in $4.5 million for its Surfacer central venous catheter.

Niederauer, the former vice president of R&D for ArthroCare‘s
ENT-Sinus division (now a part of Smith & Nephew (FTSE:SN, NYSE:SNN)), also put in time at ENTrigue Surgical, C2M Medical and OsteoBiologics, according to a press release.

"BVT has developed a critical mission to address shortcomings in the venous access market. I am honored to join the team and build upon that mission to bring superior, life-saving technologies to the market," Niederauer said in prepared remarks. "I look forward to working with the team to commercialize the innovative Surfacer System."

Bluegrass Vascular raised a $4.5 million Series A round in July that it plans to spend in pursuit of CE Mark approval in the European Union for the Surfacer device, which is designed to restore central venous access in patients with occluded veins.

"Gabriele is a great addition to the team," said Paul Castella, senior managing partner of Targeted Technology Funds, which led the Series A round. "She has over 20 years of experience in the development and commercialization of medical devices and is a great fit to lead the company to commercialization in Europe and the US."

Former CEO Jim Clifton, a co-founder, is slated for the COO role, responsible for operations, project management and market strategy, according to the release.

 Biolase confirms Nugent as CEO, promotes Arrow to CMO
Biolase (NSDQ:BIOL) said it made interim CEO Jeffrey Nugent’s role permanent and promoted COO Dr. Alexander Arrow to be its new chief medical officer. Biolase put Nugent into the corner office in June, amid a court-ordered shake-up that included the ouster of Federico Pignatelli as CEO.
Read more

 Philips Healthcare nabs BD exec for Down Under GM
Royal Philips (NYSE:PHG) named former Becton Dickinson & Co. (NYSE:BDX) executive Kevin Barrow country manager for Philips Australia and New Zealand and general manager of Philips Healthcare in those countries.
Read more

 Foundry partner Engelson is Medina Medical’s new CEO
Erik Engelson, a former partner at medical device incubator The Foundry, was named CEO of Medina Medical effective August 18.
Read more

 Poldermans beta blocker scandal trails new ESC prez Bax

A scandal is dogging the appointment of Dr. Jeroen Bax as president of the European Society of Cardiology, stemming from his close collaboration with Dr. Don Poldermans, a Dutch researcher accused of faking data in a seminal 1999 study on the use of beta blockers during vascular surgery.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • CoorsTek scores EU legal win in pink components trademark dispute
    The EU Trademark Court of Appeals in Paris recently upheld a Paris EU Trademark High Court decision that sided with CoorsTek against CeramTec in a trademark dispute over “pink” ceramic hip components. The Paris Court of Appeals in its June 2021 ruling upheld the cancelations of the three EU trademarks and the dismissal of CeramTec’s… […]
  • Abbott CMO Dr. Nick West touts latest iteration of drug-eluting stent
    Abbott executive Dr. Nick West believes the company offers the “best-in-class” drug-eluting stent with its Xience platform. When Abbott (NYSE:ABT) CMO & divisional VP of global medical affairs Dr. Nick West looks back at his use of drug-eluting stents in the early 2000s, all he sees now is innovation. As a practicing interventional cardiologist, West remembers… […]
  • Versapor® RC Membranes: The next generation of venting materials
    As the world leader in the design and production of membranes, filtration devices, and separation systems, Pall Corporation supplies products to nearly every industry in the world. Founded in 1946, Pall Corporation has set the standard for filtration solutions for 75 years and counting. Our customers have relied on us for their most sophisticated applications… […]
  • Tips to help bring your medical device from mind to market
    By Bret Ludwig, Ph.D. Senior Product Development Specialist, 3M Medical Materials & Technologies Great medical devices start with an idea—a spark. And from there, it might move to the back of a napkin or a notepad. But as development continues, the process can get trickier and more complex. In fact, turning an idea into a… […]
  • Salt baths increase stability in the medical device tempering process
    Calibration baths, like salt baths, were originally for calibrating temperature assets. But there’s another use for them: manufacturing Nitinol medical devices. Travis Porter, Fluke Calibration Nitinol is a nickel-titanium alloy that exhibits both thermal shape memory behavior and super-elasticity. It’s a great metal to use in medical devices because it’s possible to set the wire… […]
  • Traco Power announces new TMW 24 and TMW 36 series
    Traco Power (San Jose, Calif.) recently announced the company’s new TMW series of 24- and 36-W power supplies. The new power supplies are IP68 rated and fully encapsulated — with flexible options for PCB or chassis mounting for the medical and industrial markets. The TMW Series were also designed for flush box-mounting to support IoT… […]
  • Protolabs reports mixed-bag results for Q2
    Protolabs (NYSE: PRLB) posted second-quarter earnings today that missed the consensus forecast on Wall Street, though the company beat on revenue. The Maple Plain, Minn–based digital manufacturing outsourcer — which serves medtech and a host of other industries — reported profits of $12.9 million, or 47¢ per share, on sales of $123.0 million for the… […]
  • Integer beats The Street in Q2, boosts sales outlook
    Integer Holdings (NYSE:ITGR) posted second-quarter results today that beat the consensus forecast on Wall Street — boosting its 2021 sales outlook amid continued recovery from the COVID-19 pandemic. The Plano, Texas–based medical device contract manufacturing giant reported profits of $29.4 million, or 89¢ per share, on sales of $312.0 million for the three months ended… […]
  • Keep the end in mind when choosing a medtech partner
    There are five general categories of medtech vendor partners. If the end is apparent in the beginning, the correct type of partner will be clearer. Jim Reed, Minnetronix Medical Stephen Covey gave the business world this mantra in one of his bestsellers: “Start with the end in mind.” Whether they didn’t read the book or… […]
  • Orthofix launches Fiberfuse Strip bone graft
    Orthofix (NSDQ:OFIX) today announced that it has launched its FiberFuse Strip bone graft in the U.S. Lewisville, Texas–based Orthofix designed the FiberFuse Strip to be a preformed bone-graft strip for posterior cervical, posterior lumbar and degenerative spinal procedures. FiberFuse Strip is 100% bone and has a unique mixture of mineralized cancellous and demineralized cortical bone with… […]
  • Thermo Fisher Scientific beats The Street in Q2 results
    Thermo Fisher Scientific (NYSE:TMO) today posted second-quarter results that beat the overall consensus on Wall Street. The Waltham, Mass.–based company reported profits of $1.8 billion, or $4.61 per share, on sales of $9.3 billion for the three months ended July 1, 2021, for a bottom-line gain of 58.1% on sales growth of 34.1% compared with… […]

Leave a Reply